Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2011, Article ID 394896, 8 pages
http://dx.doi.org/10.1155/2011/394896
Research Article

Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study

OrygenYouth Health Centre for Youth Mental Health, University of Melbourne, Locked Bag 10, Parkville, VIC 3052, Australia

Received 2 June 2010; Accepted 31 January 2011

Academic Editor: R. A. Emsley

Copyright © 2011 J. Edwards et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Craig, S. Fennig, M. Tanenberg-Karant, and E. J. Bromet, “Six-month clinical status as a predictor of 24-month clinical outcome in first-admission patients with schizophrenia,” Annals of Clinical Psychiatry, vol. 11, no. 4, pp. 197–203, 1999. View at Google Scholar · View at Scopus
  2. J. Edwards, D. Maude, P. D. McGorry, S. M. Harrigan, and J. T. Cocks, “Prolonged recovery in first-episode psychosis,” British Journal of Psychiatry, vol. 172, no. 33, pp. 107–116, 1998. View at Google Scholar · View at Scopus
  3. K. Wahlbeck, M. Cheine, A. Essali, and C. Adams, “Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials,” American Journal of Psychiatry, vol. 156, no. 7, pp. 990–999, 1999. View at Google Scholar · View at Scopus
  4. American Psychiatric Association, “Practice guideline for the treatment of patients with schizophrenia,” The American Journal of Psychiatry, vol. 154, no. 4, supplement, pp. 1–63, 1997. View at Google Scholar
  5. P. McGorry, “Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders,” Australian and New Zealand Journal of Psychiatry, vol. 39, no. 1-2, pp. 1–30, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. C. A. Galletly, C. R. Clark, A. C. McFarlane, and D. L. Weber, “Effects of clozapine for non-treatment-resistant patients with schizophrenia,” Psychiatric Services, vol. 50, no. 1, pp. 101–103, 1999. View at Google Scholar · View at Scopus
  7. V. Drury, M. Birchwood, R. Cochrane, and F. MacMillan, “Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms,” British Journal of Psychiatry, vol. 169, pp. 593–601, 1996. View at Google Scholar · View at Scopus
  8. V. Drury, M. Birchwood, R. Cochrane, and F. Macmillan, “Cognitive therapy and recovery from acute psychosis: a controlled trial. II. Impact on recovery time,” British Journal of Psychiatry, vol. 169, no. 5, pp. 602–607, 1996. View at Google Scholar · View at Scopus
  9. G. Haddock and S. Lewis, “Psychological interventions in early psychosis,” Schizophrenia Bulletin, vol. 31, no. 3, pp. 697–704, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. N. Tarrier, S. Lewis, G. Haddock et al., “Cognitive-behavioural therapy in first-episode and early schizophrenia: 18-month follow-up of a randomised controlled trial,” British Journal of Psychiatry, vol. 184, pp. 231–239, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. P. D. McGorry, J. Edwards, C. Mihalopoulos, S. M. Harrigan, and H. J. Jackson, “EPPIC: an evolving system of early detection and optimal management,” Schizophrenia Bulletin, vol. 22, no. 2, pp. 305–326, 1996. View at Google Scholar · View at Scopus
  12. J. Edwards, D. Maude, T. Herrmann-Doig et al., “A service response to prolonged recovery in early psychosis,” Psychiatric Services, vol. 53, no. 9, pp. 1067–1069, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Ventura, M. F. Green, A. Shaner, and R. P. Libersman, “Training and quality assurance with the Brief Psychiatric Rating Scale: the 'drift busters',” International Journal of Methods in Psychiatric Research, vol. 3, pp. 221–244, 1993. View at Google Scholar
  14. T. Hermann-Doig, D. Maude, and J. Edwards, Systematic Treatment of Persistent Psychosis (STOPP): A Psychological Approach to Facilitating Recovery in Young People with First-Episode Psychosis, Martin Dunitz, London, UK, 2003.
  15. N. C. Andreasen, Scale for the Assessment of Negative Symptoms (SANS), University of Iowa, Iowa City, Iowa, USA, 1983.
  16. A. T. Beck and R. W. Beck, “Screening depressed patients in family practice. A rapid technic,” Postgraduate Medicine, vol. 52, no. 6, pp. 81–85, 1972. View at Google Scholar · View at Scopus
  17. W. Guy, “Clinical global impression,” in ECDEU Assessment Manual for Psychopharmacology, W. Guy and M. D. Rockville, Eds., pp. 76–338, US Department of Health, Education and Welfare Publication, Washington, DC, USA, 1976. View at Google Scholar
  18. H. H. Goldman, A. E. Skodol, and T. R. Lave, “Revising axis V for DSM-IV: a review of measures of social functioning,” American Journal of Psychiatry, vol. 149, no. 9, pp. 1148–1156, 1992. View at Google Scholar · View at Scopus
  19. D. W. Heinrichs, T. E. Hanlon, and W. T. Carpenter, “The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome,” Schizophrenia Bulletin, vol. 10, no. 3, pp. 388–398, 1984. View at Google Scholar · View at Scopus
  20. P. D. McGorry, D. L. Copolov, and B. S. Singh, “Royal park multidiagnostic instrument for psychosis: part I. rationale and review,” Schizophrenia Bulletin, vol. 16, no. 3, pp. 501–515, 1990. View at Google Scholar · View at Scopus
  21. P. D. McGorry, B. S. Singh, D. L. Copolov, I. Kaplan, C. R. Dossetor, and R. J. Van Riel, “Royal Park multidiagnostic instrument for psychosis: part II. Development, reliability, and validity,” Schizophrenia Bulletin, vol. 16, no. 3, pp. 517–537, 1990. View at Google Scholar · View at Scopus
  22. M. B. First, R. L. Spitzer, M. Gibbon, and J. B. W. Williams, Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition with Psychotic Screen, Biometrics Department, New York State Psychiatric Institute, New York, NY, USA, 1996.
  23. J. Edwards, M. Harris, and A. Herman, “The early psychosis prevention and intervention centre, Melbourne, Australia: an overview,” in Recent Advances in Early Intervention and Prevention in Psychiatric Disorders, C. Ogura, Ed., pp. 26–33, Seiwa Shoten Publishers, Tokyo, Japan, 2001. View at Google Scholar
  24. O. Agid, G. Remington, S. Kapur, T. Arenovich, and R. B. Zipursky, “Early use of clozapine for poorly responding first-episode psychosis,” Journal of Clinical Psychopharmacology, vol. 27, no. 4, pp. 369–373, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. A. I. Green and J. J. Schildkraut, “Should clozapine be a first-line treatment for schizophrenia? The rationale for a double-blind clinical trial in first-episode patients,” Harvard Review of Psychiatry, vol. 3, no. 1, pp. 1–9, 1995. View at Google Scholar · View at Scopus
  26. J. A. Lieberman, M. Phillips, H. Gu et al., “Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine,” Neuropsychopharmacology, vol. 28, no. 5, pp. 995–1003, 2003. View at Google Scholar · View at Scopus
  27. H. Y. Meltzer, “Clozapine: is another view valid?” American Journal of Psychiatry, vol. 152, no. 6, pp. 821–825, 1995. View at Google Scholar · View at Scopus
  28. H. J. Jackson, P. D. McGorry, E. Killackey et al., “Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project,” Psychological Medicine, vol. 38, no. 5, pp. 725–735, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. D. L. Penn, E. J. Waldheter, D. O. Perkins, K. T. Mueser, and J. A. Lieberman, “Psychosocial treatment for first-episode psychosis: a research update,” American Journal of Psychiatry, vol. 162, no. 12, pp. 2220–2232, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. H. Jackson, P. McGorry, J. Edwards et al., “Cognitively-oriented psychotherapy for early psychosis (COPE): preliminary results,” British Journal of Psychiatry, vol. 172, no. 33, pp. 93–100, 1998. View at Google Scholar · View at Scopus